Abstract
BackgroundHemodialysis (HD) patients are considered to be at increased risk for developing rheumatoid arthritis (RA), as a result of immunologic abnormalities caused by this treatment1). Anti-cyclic citrullinated peptide (anti-CCP) antibody...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
